Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Lythgoe

Showing results (61-70 of 95) with videos related to

Pageof 10
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 4, 2018
Correction: Prefrontal GABA levels, hippocampal resting perfusion and the risk of psychosisGemma Modinos, Fatma Şimşek, Matilda Azis, et al.
Schizophrenia Research|September 1, 2023
Treatment resistance NMDA receptor pathway polygenic score is associated with brain glutamate in schizophreniaKira Griffiths, Sophie E Smart, Gareth J Barker, et al.
Brain, Behavior, and Immunity|February 11, 2026
Multimodal imaging suggests potential immune-vascular contributions to altered regional brain perfusion and oxygen metabolism in Post-COVID-19 SyndromeDaniel Martins, Matthew Burrows, Owen O' Daily, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 12, 2014
Relationship between brain glutamate levels and clinical outcome in individuals at ultra high risk of psychosisAlice Egerton, James M Stone, Christopher A Chaddock, et al.
Schizophrenia Bulletin|January 5, 2021
Changes in Brain Glutamate on Switching to Clozapine in Treatment-Resistant SchizophreniaGrant McQueen, Kyra-Verena Sendt, Amy Gillespie, et al.
Schizophrenia (Heidelberg, Germany)|March 3, 2022
Subcortical volume reduction and cortical thinning 3 months after switching to clozapine in treatment resistant schizophreniaFanni Krajner, Laila Hadaya, Grant McQueen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumAna Bea Solana Sanchez, Brice Fernandez, David J Lythgoe, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersAna Bea Solana Sanchez, Brice Fernandez, David J Lythgoe, et al.
Translational Psychiatry|September 20, 2022
From bench to bedside: The mGluR5 system in people with and without Autism Spectrum Disorder and animal model systemsCornelia Carey, Nisha Singh, Joel T Dunn, et al.
Neurology|July 13, 2014
Preventing visual field deficits from neurosurgeryGavin P Winston, Pankaj Daga, Mark J White, et al.
Pageof 10

Showing results (61-70 of 95) with videos related to

Sort By:
Pageof 10
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 4, 2018
Correction: Prefrontal GABA levels, hippocampal resting perfusion and the risk of psychosisGemma Modinos, Fatma Şimşek, Matilda Azis, et al.
Schizophrenia Research|September 1, 2023
Treatment resistance NMDA receptor pathway polygenic score is associated with brain glutamate in schizophreniaKira Griffiths, Sophie E Smart, Gareth J Barker, et al.
Brain, Behavior, and Immunity|February 11, 2026
Multimodal imaging suggests potential immune-vascular contributions to altered regional brain perfusion and oxygen metabolism in Post-COVID-19 SyndromeDaniel Martins, Matthew Burrows, Owen O' Daily, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 12, 2014
Relationship between brain glutamate levels and clinical outcome in individuals at ultra high risk of psychosisAlice Egerton, James M Stone, Christopher A Chaddock, et al.
Schizophrenia Bulletin|January 5, 2021
Changes in Brain Glutamate on Switching to Clozapine in Treatment-Resistant SchizophreniaGrant McQueen, Kyra-Verena Sendt, Amy Gillespie, et al.
Schizophrenia (Heidelberg, Germany)|March 3, 2022
Subcortical volume reduction and cortical thinning 3 months after switching to clozapine in treatment resistant schizophreniaFanni Krajner, Laila Hadaya, Grant McQueen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumAna Bea Solana Sanchez, Brice Fernandez, David J Lythgoe, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersAna Bea Solana Sanchez, Brice Fernandez, David J Lythgoe, et al.
Translational Psychiatry|September 20, 2022
From bench to bedside: The mGluR5 system in people with and without Autism Spectrum Disorder and animal model systemsCornelia Carey, Nisha Singh, Joel T Dunn, et al.
Neurology|July 13, 2014
Preventing visual field deficits from neurosurgeryGavin P Winston, Pankaj Daga, Mark J White, et al.
Pageof 10